News | Patient Positioning Radiation Therapy | July 03, 2019

Couchtop allows effective proton therapy treatment of central nervous system cancers

Civco Displaying Universal Couchtop ProForm Head & Neck Solution at AAPM

July 3, 2019 — The upcoming release of Civco’s Universal Couchtop ProForm Head & Neck Solution will allow proton therapy centers direct access to effectively treat central nervous system (CNS) cancer patients.

The extension is quick and easy to attach and features a large, 121.5 cm junction-free and artifact-free treatment area. The ProForm contains a homogeneous treatment area with soft gradient edges that reduce beam degradation. ProForm accepts a thermoplastic mask with a smaller profile frame and pin similar to Civco’s Type-S system. The ProForm solution follows the Universal Couchtop release with IBA’s Proteus One and Proteus Plus. Utilizing the Universal Couchtop allows dosimetric consistency with computed tomography (CT) simulation, photon and proton treatment compatible models, improving clinic workflow.

Civco will display the Universal Couchtop at the 2019 American Association of Physicists in Medicine (AAPM) annual meeting, July 14-18 in San Antonio, Texas.

For more information: www.civcort.com


Related Content

News

Aug. 5, 2024 — Researchers from The University of Texas MD Anderson Cancer Center have demonstrated that adding ...

Time August 09, 2024
arrow
News | Radiology Business

July 31, 2024 — The American Registry of Radiologic Technologists (ARRT) announced the three Registered Technologists (R ...

Time July 31, 2024
arrow
News | PET-CT

July 31, 2024 — In a head-to-head comparison with FDG PET/CT, FDG PET/MRI demonstrated comparable or superior diagnostic ...

Time July 31, 2024
arrow
Feature | Radiation Oncology | By Christine Book

News emerging from several leading organizations and vendors in the radiation therapy arena came in at a fast pace in ...

Time July 30, 2024
arrow
News | Radiopharmaceuticals and Tracers

July 24, 2024 — Telix Pharmaceuticals Limited announced that the United States (U.S.) Food and Drug Administration (FDA) ...

Time July 24, 2024
arrow
News | Radiation Therapy

July 22, 2024 — RefleXion Medical, an external-beam theranostic oncology company, today announced that researchers from ...

Time July 22, 2024
arrow
News | ASTRO

July 18, 2024 — The members of the American Society for Radiation Oncology (ASTRO) recently elected five new officers to ...

Time July 18, 2024
arrow
News | PET-CT

July 16, 2024 — A new research paper was published in Oncotarget's Volume 15 on June 20, 2024, titled, “Comparison of ...

Time July 16, 2024
arrow
News | Digital Pathology

July 12, 2024 — AGFA HealthCare, a global leader in healthcare imaging management solutions, announced that Enterprise ...

Time July 12, 2024
arrow
News | Digital Pathology

July 12, 2024 — Diagnosing cancer and providing the personalized therapy it often requires, is a collaborative effort ...

Time July 12, 2024
arrow
Subscribe Now